Background
Methods
Study design
Selection criteria and data collection procedure
Data source
Data extraction process
Data management
Results
Types of investigators
Parameters | Tally | Frequency (%) |
---|---|---|
Sex | ||
Male | 1223 | 56.6 |
Female | 860 | 39.8 |
Unknown | 89 | 4.10 |
Country of origin | ||
Cameroon | 1842 | 87.8 |
Other | 330 | 15.2 |
Professional background | ||
Specialist in Medicine | 360 | 52.3 |
Pharmacist | 13 | 1.9 |
Biologist | 118 | 17.2 |
Public health | 90 | 13.1 |
Others | 107 | 15.6 |
Institution of investigator | ||
University | 1664 | 77.1 |
Hospital | 106 | 4.9 |
Pharmaceutical company | 13 | 0.6 |
NGO | 255 | 11.9 |
Others | 96 | 4.5 |
Professional grade | ||
PhD | 644 | 31.6 |
Masters | 232 | 11.4 |
Undergraduate | 108 | 5.3 |
Physician | 1056 | 51.8 |
Type and setting of research
Study Design stratified by student versus professional investigators | |||
Students (%) | Professional (%) |
P-value | |
Cross sectional | 820 (56.4) | 328 (45.7) | <0.001 |
Longitudinal | 256 (17.6) | 272 (37.9) | <0.001 |
Case control | 71 (4.9) | 29 (4.0) | 0.36 |
Cohort | 298 (20.5) | 77 (10.7) | <0.001 |
Case series | 4 (0.3) | 4 (0.6) | 0.31 |
Ecological studies | 2 (0.2) | 8 (1.2) | <0.001 |
Others | 3 (0.2) | 0 | 0.24 |
Total | 1454 | 718 | |
Study Design stratified by local sponsors versus international sponsors | |||
Local sponsor (%) | International (%) | ||
Cross sectional | 844 (55.1) | 109 (37.3) | <0.001 |
Longitudinal | 320 (20.9) | 135 (46.2) | <0.001 |
Case control | 68 (4.4) | 14 (4.8) | 0.76 |
Cohort | 285 (18.6) | 31 (10.6) | <0.001 |
Case series | 8 (0.5) | 0 | 0.23 |
Ecological studies | 5 (0.3) | 3 (1.0) | 0.09 |
Others | 1 (0.1) | 0 | 0.59 |
Total | 1531 | 292 | |
Study Settings stratified by students versus professional | |||
Students (%) | Professional (%) | ||
Laboratory | 84 (6.1) | 99 (13.5) | <0.001 |
Hospital | 1104 (80.2) | 424 (57.8) | <0.001 |
Community | 126 (9.2) | 176 (24.0) | <0.001 |
Other | 63 (4.6) | 35 (4.8) | 0.84 |
Total | 1377 | 734 | |
Study Settings stratified by local sponsor versus international sponsor | |||
Local Sponsor (%) | International (%) | ||
Laboratory | 128 (8.0) | 43 (13.7) | <0.001 |
Hospital | 1196 (75.0) | 178 (56.5) | <0.001 |
Community | 198 (12.4) | 77 (24.4) | <0.001 |
Other | 72 (4.5) | 17 (5.4) | 0.49 |
Total | 1594 | 315 | |
Result Dissemination Plan | |||
Have a result dissemination plan | Local Sponsors | International Sponsors |
p-value |
Yes | 137(7.6) | 107 (29.0) | <0.001 |
No | 1666 (92.4) | 262 (71.0) | |
Total | 1803 | 369 |
Geographical distribution of research projects
Health Region | Number of Research projects (%) | Percentage of general population represented in 2012 (%) |
---|---|---|
Adamawa | 12 (0.5) | 5.3 |
Centre | 1242 (57.2) | 18.3 |
East | 14 (0.6) | 4.0 |
Far North | 28 (1.3) | 18.0 |
Littoral | 195 (9.0) | 14.9 |
North | 15 (0.7) | 10.9 |
North West | 55 (2.5) | 9.1 |
South | 32 (1.5) | 3.5 |
South West | 44 (2.0) | 7 |
West | 115 (5.3) | 9.0 |
Multiple regions | 419 (19.3) | |
Total | 2172 | 20,386,800 |
Research domains and target populations
Health Domains stratified by origin of sponsor | ||||
Health Domain | Total (%) | Local (%) | International (%) |
p-value |
Mother/child/Adolescent | 416 (19.3) | 377 (21.0) | 23 (6.3) | <0.001 |
Fight against Diseases | 1323 (61.3) | 1084 (60.4) | 249 (68.0) | 0.01 |
Health promotion | 170(7.9) | 128 (7.1) | 39 (10.6) | 0.02 |
District Viability | 60 (2.8) | 45 (2.5) | 14 (3.9) | 0.13 |
Health determinants | 191 (8.8) | 160 (8.9) | 41(11.2) | 0.17 |
Total | 2160 (100) | 1794 | 366 | |
Target Populations stratified by origin of sponsor | ||||
Target Population | Total | Local (%) | International (%) |
p-value |
Child | 342 (16.2) | 306 (17.3) | 36 (10.1) | <0.001 |
Adolescent | 74 (3.5) | 60 (3.4) | 10 (2.8) | 0.57 |
Women | 346 (16.3) | 307 (17.4) | 39 (10.4) | <0.001 |
Men | 21 (1.0) | 19 (1.1) | 3 (0.9) | 0.74 |
Adults | 683 (32.3) | 538 (30.5) | 152 (43.2) | <0.001 |
All Ages | 651 (30.8) | 537 (30.4) | 114 (32.5) | 0.44 |
Total | 2117 (100) | 1766 | 351 |
Target diseases of the research
Diseases | Total (%) | Local sponsors (%) | International Sponsor (%) |
p-value |
---|---|---|---|---|
Diabetes | 101 (7.6) | 90 (8.1) | 11 (5.1) | 0.13 |
HIV/AIDS | 342 (25.8) | 306 (27.6) | 36 (16.7) | <0.001 |
Malaria | 136 (10.3) | 99 (8.9) | 37 (17.2) | <0.001 |
Tuberculosis | 44 (3.3) | 39 (3.5) | 5 (2.3) | 0.37 |
Reproductive Health | 33 (2.5) | 29 (2.6) | 4 (1.9) | 0.55 |
Cancers | 77 (5.8) | 53 (4.8) | 24 (11.2) | <0.001 |
Neurological/Mental Health | 61 (4.6) | 49 (4.4) | 12 (5.6) | 0.44 |
Cardiovascular Diseases | 64 (4.8) | 57 (5.1) | 7(3.3) | 0.26 |
Metabolic Diseases | 37 (2.8) | 33 (3.0) | 4 (1.9) | 0.37 |
Digestive System | 54 (4.1) | 51 (4.6) | 3 (1.4) | 0.03 |
Tropical/Infectious Diseases | 126 (9.5) | 107 (9.7) | 19 (8.8) | 0.68 |
Eye Diseases | 19 (1.4) | 15 (1.3) | 4 (1.9) | 0.49 |
Respiratory system diseases | 38 (2.9) | 29 (2.6) | 9 (4.2) | 0.20 |
STI/STD | 17(1.3) | 14(1.3) | 3 (1.4) | 0.91 |
Hepatitis | 44 3.3) | 35(3.20) | 9 (4.2) | 0.46 |
Others | 130 (9.8) | 102 (9.2) | 28 (13.0) | 0.09 |
Total | 1323 | 1108 | 215 |